We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.
cancel
-
5HT3 and Dexamethasone in Pediatric Patients - Chemotherapy-Induced Nausea and Vomiting—Pediatric
-
Serotonin 5HT3 Receptor Antagonists (5HT3) - Chemotherapy-Induced Nausea and Vomiting—Pediatric
-
Neurokinin-1 Receptor Antagonist (NK1) - Chemotherapy-Induced Nausea and Vomiting—Pediatric
-
Lorazepam - Chemotherapy-Induced Nausea and Vomiting—Adult
-
Haloperidol - Chemotherapy-Induced Nausea and Vomiting—Adult
-
Acupuncture/Electroacupuncture - Chemotherapy-Induced Nausea and Vomiting—Adult
-
Acupressure - Chemotherapy-Induced Nausea and Vomiting—Adult
-
Single Agent Dexamethasone - Chemotherapy-Induced Nausea and Vomiting—Adult
-
Olanzapine for Breakthrough CINV - Chemotherapy-Induced Nausea and Vomiting—Adult
-
Benzodiazepine for Anticipatory Chemotherapy-Induced Nausea and Vomiting. - Chemotherapy-Induced Nausea and Vomiting—Adult
Subscribe to